Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy

Cytokine

Volumn 54, Issue 2, 2011, Pages 212-217

  Symeonidis, Chrysanthos ^a,b   Papakonstantinou, Eleni ^b   Androudi, Sofia ^c   Rotsos, Tryfon ^a   Diza, Eudoxia ^d   Brazitikos, Periklis ^b   Karakiulakis, George ^b   Dimitrakos, Stavros A ^b  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

^d AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Interleukin 6; Matrix metalloproteinases; Proliferative vitreoretinopathy; Rhegmatogenous retinal detachment; Vitreous fluid

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DISEASE DURATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FEMALE; GELATINIZATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA DETACHMENT; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY; ZYMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 79953040291     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.02.001     Document Type: Article

References (36)

1. Asaria R.H., Charteris D.G. Proliferative vitreoretinopathy: developments in pathogenesis and treatment. Compr Ophthalmol Update 2006, 7:179-185.
2. Song M., Kellum J.A. Interleukin-6. Crit Care Med 2005, 33:S463-S465.
3. Nakahara H., Song J., Sugimoto M., et al. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum 2003, 48:1521-1529.
4. Nishimoto N., Kishimoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2006, 2:619-626.
5. Planck S.R., Dang T.T., Graves D., Tara D., Ansel J.C., Rosenbaum J.T. Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1. Invest Ophthalmol Vis Sci 1992, 33:78-82.
6. Kon C.H., Occleston N.L., Aylward G.W., Khaw P.T. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci 1999, 40:705-712.
7. Kenarova B., Voinov L., Apostolov C., Vladimirova R., Misheva A. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment. Eur J Ophthalmol 1997, 7:64-67.
8. Tojo N., Kashiwagi Y., Nishitsuka K., et al. Interactions between vitreous-derived cells and vascular endothelial cells in vitreoretinal diseases. Acta Ophthalmol 2010, 88:564-570.
9. Li D.Q., Lokeshwar B.L., Solomon A., Monroy D., Ji Z., Pflugfelder S.C. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 2001, 73:449-459.
10. Legendre F., Bogdanowicz P., Boumediene K., Pujol J.P. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular. J Rheumatol 2005, 32:1307-1316.
11. Luckett L.R., Gallucci R.M. Interleukin-6 (IL-6) modulates migration and matrix metalloproteinase function in dermal fibroblasts from IL-6KO mice. Br J Dermatol 2007, 156:1163-1171.
12. Sethi C.S., Bailey T.A., Luthert P.J., Chong N.H. Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol 2000, 84:654-666.
13. Sivak J.M., Fini E. MMPs in the eye: emerging roles for matrix metallo-proteinases in ocular pathology. Prog Retin Eye Res 2002, 21:1-14.
14. Bachmeier B.E., Nerlich A.G., Boukamp P., et al. Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases -1, -8 and -13 and of TIMP-1. Biol Chem 2000, 381:509-516.
15. Symeonidis C., Diza E., Papakonstantinou E., Souliou E., Karakiulakis G., Dimitrakos S.A. Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 2007, 245:560-568.
16. Abu El-Asrar A.M., Dralands L., Veckeneer M., et al. Gelatinase B in proliferative vitreoretinal disorders. Am J Ophthalmol 1998, 125:844-851.
17. Symeonidis C., Diza E., Papakonstantinou E., Souliou E., Dimitrakos S.A., Karakiulakis G. Correlation of the extent and duration of rhegmatogenous retinal detachment with the expression of matrix metalloproteinases in the vitreous. Retina 2007, 27:1279-1285.
18. Webster L., Chignell A.H., Limb G.A. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy. Exp Eye Res 1999, 68:91-98.
19. Salzmann J., Limb G.A., Khaw P.T. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 2000, 84:1091-1096.
20. Sheridan C.M., Occleston N.L., Hiscott P., Kon C.H., Khaw P.T., Grierson I. Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue. Am J Pathol 2001, 159:1555-1566.
21. Zhang X., Sakamoto T., Hata Y., et al. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-perfusion injury in rats. Exp Eye Res 2002, 74:577-584.
22. Rutges J.P., Kummer J.A., Oner F.C., et al. Increased MMP-2 activity during intervertebral disc degeneration is correlated to MMP-14 levels. J Pathol 2008, 214:523-530.
23. Armstrong P.W., Moe G.W., Howard R.J., Grima E.A., Cruz T.F. Structural remodelling in heart failure: gelatinase induction. Can J Cardiol 1994, 10:214-220.
24. Adithi M., Nalini V., Kandalam M., Krishnakumar S. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma. J Pediatr Hematol Oncol 2007, 29:399-405.
25. Meller D., Li D.Q., Tseng S.C. Regulation of collagenase, stromelysin and gelatinase B in human conjuctival and conjuctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha. Invest Ophthalmol Vis Sci 2000, 41:2922-2929.
26. Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1983;90:121-25.
27. Karakiulakis G., Papanikolaou C., Jankovic S.M., et al. Increased type IV collagen degrading activity in metastases originating from primary tumors of the human colon. Invasion Metastasis 1997, 17:158-168.
28. Limb G.A., Alam A., Earley O., Green W., Chignell A.H., Dumonde D.C. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res 1994, 13:791-798.
29. La Heij E.C., Van De Waarenburg M.P., Blaauwgeers H.G., et al. Levels of basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in subretinal fluid from patients with retinal detachment. Am J Ophthalmol 2001, 132:544-550.
30. La Heij E.C., van de Waarenburg M.P., Blaauwgeers H.G., et al. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy. Am J Ophthalmol 2002, 134:367-375.
31. Limb G.A., Earley O., Jones S.E., LeRoy F., Chignell A.H., Dumonde D.C. Expression of mRNA coding for TNF alpha, IL-1 beta and IL-6 by cells infiltrating retinal membranes. Graefes Arch Clin Exp Ophthalmol 1994, 232:646-651.
32. Lin T., Zhang W., Fan Y., Mulholland M. Interleukin-1beta and interleukin-6 stimulate matrix metalloproteinase-9 secretion in cultured myenteric glia. J Surg Res 2007, 137:38-45.
33. Yao J.S., Zhai W., Young W.L., Yang G.Y. Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochem Biophys Res Commun 2006, 342:1396-1404.
34. Parshley D.E., Bradley J.M., Samples J.R., Van Buskirk E.M., Acott T.S. Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr Eye Res 1995, 14:537-544.
35. Brew K., Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 2010, 1803:55-71.
36. Symeonidis C., Papakonstantinou E., Souliou E., Karakiulakis G., Dimitrakos S.A., Diza E. Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment. Acta Ophthalmol 2009, [Epub ahead of print].